Your browser doesn't support javascript.
loading
A randomized, double-blind, placebo-controlled investigation of BCc1 nanomedicine effect on survival and quality of life in metastatic and non-metastatic gastric cancer patients.
Hafizi, Maryam; Kalanaky, Somayeh; Moaiery, Hassan; Khayamzadeh, Maryam; Noorian, Sajad; Kaveh, Vahid; Gharib, Behrooz; Foudazi, Hossein; Razavi, Mohsen; Jenabian, Arash; Salimi, Saeid; Sereshki, Mohammad Mahdi Adib; Mirzaei, Hamid Reza; Zarghi, Afshin; Fakharzadeh, Saideh; Nazaran, Mohammad Hassan; Akbari, Mohammad Esmaeil.
Afiliación
  • Hafizi M; Cancer Research Centre, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Kalanaky S; Department of Research and Development, Sodour Ahrar Shargh Company, Tehran, Iran.
  • Moaiery H; Department of Research and Development, Sodour Ahrar Shargh Company, Tehran, Iran.
  • Khayamzadeh M; Cancer Research Centre, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Noorian S; Cancer Research Centre, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Kaveh V; Department of Statistics, Faculty of Sciences, University of Qom, Qom, Iran.
  • Gharib B; Firouzgar Hospital, Iran University of Medical Sciences, Tehran, Iran.
  • Foudazi H; Naft Company Hospital, Tehran, Iran.
  • Razavi M; Shahid Fayaz-Bakhsh Hospital, Tehran, Iran.
  • Jenabian A; Firouzgar Hospital, Iran University of Medical Sciences, Tehran, Iran.
  • Salimi S; Department of Medical Oncology and Hematology, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran.
  • Sereshki MMA; Firouzgar Hospital, Iran University of Medical Sciences, Tehran, Iran.
  • Mirzaei HR; Firouzgar Hospital, Iran University of Medical Sciences, Tehran, Iran.
  • Zarghi A; Cancer Research Centre, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Fakharzadeh S; Department of Medicinal and Pharmaceutical Chemistry, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Nazaran MH; Department of Research and Development, Sodour Ahrar Shargh Company, Tehran, Iran.
  • Akbari ME; Department of Research and Development, Sodour Ahrar Shargh Company, Tehran, Iran. mnazaran@nanochelatingtechnology.com.
J Nanobiotechnology ; 17(1): 52, 2019 Apr 10.
Article en En | MEDLINE | ID: mdl-30971278
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Adenocarcinoma / Nanocompuestos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Aged80 / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: J Nanobiotechnology Año: 2019 Tipo del documento: Article País de afiliación: Irán
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Adenocarcinoma / Nanocompuestos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Aged80 / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: J Nanobiotechnology Año: 2019 Tipo del documento: Article País de afiliación: Irán